Table 1 Participant characteristics.

From: Unexpectedly low prevalence of hepatitis delta virus infection in Southern Viet Nam

Characteristic

Median

(Interquartile range)

Flare

(n = 158)

LC

(n = 181)

HCC

(n = 207)

CHB

(n = 175)

p-value

Age (years)

44 (37–53)

56 (49–66)

61 (54–68)

47 (40–56)

< 0.0001

Female/male

(%/%)

36/122

22.8/77.2

71/110

39.3/60.7

40/167

17.9/82.1

84/91

48/52.0

< 0.0001#

ALT (U/L)

577 (336–1248)

34 (24–55)

36 (24–52)

23 (17–31)

< 0.0001

AST (U/L)

397 (221–826)

45 (34–65)

47 (31–77)

27 (23–31)

< 0.0001

GGT (U/L)

192 (119–314)

58 (32–96)

97 (50–226)

23 (17–36)

< 0.0001

Albumin (g/L)

38.4

(32.9–41.7)

40.2

(35.1–44.2)

41.0

(35.4–43.3)

NA

< 0.0001

Total Bilirubin (mg/dL)

3.43

(1.07–18.66)

1.14

(0.82–1.67)

0.86

(0.67–1.35)

NA

< 0.0001

Platelets (K/uL)

204

(155–260)

117

(80–143)

174

(127–245)

240.5

(206–285)

< 0.0001

Positive qualitative HBeAg (%)

45.0

21.3

26.7

20.0

< 0.0001#

HBV-DNA (log IU/mL)*

6.7

(3.97–7.97)

2.21

(1.23–4.54)

2.41

(1.00–4.81.00.81)

3.45

(2.18–5.33)

< 0.0001

  1. ALT: Alanine aminotransferase, AST: Aspartate aminotransferase, GGT: gamma-glutamyl transferase, HBeAg: Hepatitis B e-antigen. *: HBV-DNA measurements in all groups were collected from the medical records at or within 3 months of sampling. Undetectable HBV-DNA levels were assigned to the lower limit of quantification of 10 IU/mL or 1.00 log HBV-DNA (IU/mL). #: Features were compared by the Chi-square test. Other features were compared by the Kruskal-Wallis test.